A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Overview

This article presents a cell-based assay for reporting HIV-1 fusion through green fluorescent protein expression, detectable via flow cytometry or fluorescence microscopy. The method is applicable for testing inhibitors of viral entry during the fusion step in both cell-free and cell-to-cell infection systems.

Key Study Components

Area of Science

• Virology
• Cell Biology
• Drug Discovery

Background

• HIV-1 fusion is a critical step in viral entry.
• Understanding this process can aid in drug discovery.
• High throughput screening is essential for identifying effective inhibitors.
• Research must adhere to biosafety regulations when handling infectious HIV-1.

Purpose of Study

• To develop a scalable assay for HIV-1 fusion detection.
• To facilitate the screening of compounds targeting early HIV-1 life cycle stages.
• To evaluate HIV fusion inhibitors in relevant animal models.

Methods Used

• Cell-based assay utilizing green fluorescent protein.
• Flow cytometry and fluorescence microscopy for detection.
• Screening of large compound libraries.
• Application in humanized mouse models for in vivo studies.

Main Results

• Successful detection of HIV-1 fusion events.
• Identification of potential inhibitors from compound libraries.
• Demonstrated scalability for high throughput screening.
• Provided insights into HIV fusion mechanisms in animal models.

Conclusions

• The assay is a valuable tool for HIV research.
• It enables the discovery of novel antiviral compounds.
• Future studies can expand on the findings in various biological contexts.

Frequently Asked Questions